Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 301 entries
Sorted by: Best Match Show Resources per page
Hierarchical organization of cartilage proteoglycans.

Macromolecular symposia

Horkay F, Basser PJ, Hecht AM, Geissler E.
PMID: 23565043
Macromol Symp. 2011 Sep;306(1):11-17. doi: 10.1002/masy.201000115.

The hierarchical organization of cartilage proteoglycans is investigated on different length and time scales using osmotic pressure measurements, small angle neutron scattering (SANS), small angle X-ray scattering (SAXS), static and dynamic light scattering and neutron spin echo techniques. Osmotic...

Cite
Horkay F, Basser PJ, Hecht AM, et al. Hierarchical organization of cartilage proteoglycans. Macromol Symp. 2011;306(1):11-17doi: 10.1002/masy.201000115.
Horkay, F., Basser, P. J., Hecht, A. M., & Geissler, E. (2011). Hierarchical organization of cartilage proteoglycans. Macromolecular symposia, 306(1), 11-17. https://doi.org/10.1002/masy.201000115
Horkay, Ferenc, et al. "Hierarchical organization of cartilage proteoglycans." Macromolecular symposia vol. 306,1 (2011): 11-17. doi: https://doi.org/10.1002/masy.201000115
Horkay F, Basser PJ, Hecht AM, Geissler E. Hierarchical organization of cartilage proteoglycans. Macromol Symp. 2011 Sep;306(1):11-17. doi: 10.1002/masy.201000115. PMID: 23565043; PMCID: PMC3615634.
Copy Download .nbib Format: NLM
Non-Mammalian Vertebrates: Distinct Models to Assess the Role of Ion Gradients in Energy Expenditure.

Frontiers in endocrinology

Geisler CE, Kentch KP, Renquist BJ.
PMID: 28919880
Front Endocrinol (Lausanne). 2017 Sep 01;8:224. doi: 10.3389/fendo.2017.00224. eCollection 2017.

Animals store metabolic energy as electrochemical gradients. At least 50% of mammalian energy is expended to maintain electrochemical gradients across the inner mitochondrial membrane (H

Cite
Geisler CE, Kentch KP, Renquist BJ. Non-Mammalian Vertebrates: Distinct Models to Assess the Role of Ion Gradients in Energy Expenditure. Front Endocrinol (Lausanne). 2017;8:224doi: 10.3389/fendo.2017.00224.
Geisler, C. E., Kentch, K. P., & Renquist, B. J. (2017). Non-Mammalian Vertebrates: Distinct Models to Assess the Role of Ion Gradients in Energy Expenditure. Frontiers in endocrinology, 8224. https://doi.org/10.3389/fendo.2017.00224
Geisler, Caroline E, et al. "Non-Mammalian Vertebrates: Distinct Models to Assess the Role of Ion Gradients in Energy Expenditure." Frontiers in endocrinology vol. 8 (2017): 224. doi: https://doi.org/10.3389/fendo.2017.00224
Geisler CE, Kentch KP, Renquist BJ. Non-Mammalian Vertebrates: Distinct Models to Assess the Role of Ion Gradients in Energy Expenditure. Front Endocrinol (Lausanne). 2017 Sep 01;8:224. doi: 10.3389/fendo.2017.00224. eCollection 2017. PMID: 28919880; PMCID: PMC5585156.
Copy Download .nbib Format: NLM
Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target.

Pharmacology research & perspectives

Ankrom W, Wood HB, Xu J, Geissler W, Bateman T, Chatterjee MS, Feng KI, Metzger JM, Strapps WR, Tadin-Strapps M, Seiffert D, Andre P.
PMID: 26977298
Pharmacol Res Perspect. 2016 Jan 15;4(1):e00207. doi: 10.1002/prp2.207. eCollection 2016 Feb.

The benefits of novel oral anticoagulants are hampered by bleeding. Since coagulation factor IX (fIX) lies upstream of fX in the coagulation cascade, and intermediate levels have been associated with reduced incidence of thrombotic events, we evaluated the viability...

Cite
Ankrom W, Wood HB, Xu J, et al. Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacol Res Perspect. 2016;4(1):e00207doi: 10.1002/prp2.207.
Ankrom, W., Wood, H. B., Xu, J., Geissler, W., Bateman, T., Chatterjee, M. S., Feng, K. I., Metzger, J. M., Strapps, W. R., Tadin-Strapps, M., Seiffert, D., & Andre, P. (2016). Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacology research & perspectives, 4(1), e00207. https://doi.org/10.1002/prp2.207
Ankrom, Wendy, et al. "Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target." Pharmacology research & perspectives vol. 4,1 (2016): e00207. doi: https://doi.org/10.1002/prp2.207
Ankrom W, Wood HB, Xu J, Geissler W, Bateman T, Chatterjee MS, Feng KI, Metzger JM, Strapps WR, Tadin-Strapps M, Seiffert D, Andre P. Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacol Res Perspect. 2016 Jan 15;4(1):e00207. doi: 10.1002/prp2.207. eCollection 2016 Feb. PMID: 26977298; PMCID: PMC4777260.
Copy Download .nbib Format: NLM
Biobanking from the patient perspective.

Research involvement and engagement

Mitchell D, Geissler J, Parry-Jones A, Keulen H, Schmitt DC, Vavassori R, Matharoo-Ball B.
PMID: 29062493
Res Involv Engagem. 2015 Jun 25;1:4. doi: 10.1186/s40900-015-0001-z. eCollection 2015.

PLAIN ENGLISH SUMMARY: Biobanks are collections of donations of biological material (DNA, cells, tissue etc.) and related data which are very valuable for research into human diseases. A variety of biobanks exist for example within hospitals, research institutes, pharmaceutical...

Cite
Mitchell D, Geissler J, Parry-Jones A, et al. Biobanking from the patient perspective. Res Involv Engagem. 2015;1:4doi: 10.1186/s40900-015-0001-z.
Mitchell, D., Geissler, J., Parry-Jones, A., Keulen, H., Schmitt, D. C., Vavassori, R., & Matharoo-Ball, B. (2015). Biobanking from the patient perspective. Research involvement and engagement, 14. https://doi.org/10.1186/s40900-015-0001-z
Mitchell, Derick, et al. "Biobanking from the patient perspective." Research involvement and engagement vol. 1 (2015): 4. doi: https://doi.org/10.1186/s40900-015-0001-z
Mitchell D, Geissler J, Parry-Jones A, Keulen H, Schmitt DC, Vavassori R, Matharoo-Ball B. Biobanking from the patient perspective. Res Involv Engagem. 2015 Jun 25;1:4. doi: 10.1186/s40900-015-0001-z. eCollection 2015. PMID: 29062493; PMCID: PMC5598087.
Copy Download .nbib Format: NLM
Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials.

Journal of cancer research and clinical oncology

Taieb J, Rivera F, Siena S, Karthaus M, Valladares-Ayerbes M, Gallego J, Geissler M, Koukakis R, Demonty G, Peeters M.
PMID: 29450632
J Cancer Res Clin Oncol. 2018 Apr;144(4):795-797. doi: 10.1007/s00432-018-2591-y.

The authors would like to include the following changes in the published article.

Cite
Taieb J, Rivera F, Siena S, et al. Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials. J Cancer Res Clin Oncol. 2018;144(4):795-797doi: 10.1007/s00432-018-2591-y.
Taieb, J., Rivera, F., Siena, S., Karthaus, M., Valladares-Ayerbes, M., Gallego, J., Geissler, M., Koukakis, R., Demonty, G., & Peeters, M. (2018). Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials. Journal of cancer research and clinical oncology, 144(4), 795-797. https://doi.org/10.1007/s00432-018-2591-y
Taieb, Julien, et al. "Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials." Journal of cancer research and clinical oncology vol. 144,4 (2018): 795-797. doi: https://doi.org/10.1007/s00432-018-2591-y
Taieb J, Rivera F, Siena S, Karthaus M, Valladares-Ayerbes M, Gallego J, Geissler M, Koukakis R, Demonty G, Peeters M. Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials. J Cancer Res Clin Oncol. 2018 Apr;144(4):795-797. doi: 10.1007/s00432-018-2591-y. PMID: 29450632; PMCID: PMC6828254.
Copy Download .nbib Format: NLM
Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma.

Frontiers in immunology

van Beek AE, Pouw RB, Brouwer MC, van Mierlo G, Geissler J, Ooijevaar-de Heer P, de Boer M, van Leeuwen K, Rispens T, Wouters D, Kuijpers TW.
PMID: 29093712
Front Immunol. 2017 Oct 18;8:1328. doi: 10.3389/fimmu.2017.01328. eCollection 2017.

The complement factor H-related (FHR) proteins are hypothesized to fine-tune the regulatory role of complement factor H (FH) in the alternative pathway of the complement system. Moreover, FHR-1, FHR-2, and FHR-5 have been proposed to be dimers, which further...

Cite
van Beek AE, Pouw RB, Brouwer MC, et al. Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma. Front Immunol. 2017;8:1328doi: 10.3389/fimmu.2017.01328.
van Beek, A. E., Pouw, R. B., Brouwer, M. C., van Mierlo, G., Geissler, J., Ooijevaar-de Heer, P., de Boer, M., van Leeuwen, K., Rispens, T., Wouters, D., & Kuijpers, T. W. (2017). Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma. Frontiers in immunology, 81328. https://doi.org/10.3389/fimmu.2017.01328
van Beek, Anna E, et al. "Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma." Frontiers in immunology vol. 8 (2017): 1328. doi: https://doi.org/10.3389/fimmu.2017.01328
van Beek AE, Pouw RB, Brouwer MC, van Mierlo G, Geissler J, Ooijevaar-de Heer P, de Boer M, van Leeuwen K, Rispens T, Wouters D, Kuijpers TW. Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma. Front Immunol. 2017 Oct 18;8:1328. doi: 10.3389/fimmu.2017.01328. eCollection 2017. PMID: 29093712; PMCID: PMC5651247.
Copy Download .nbib Format: NLM
Cisgenic apple trees; development, characterization, and performance.

Frontiers in plant science

Krens FA, Schaart JG, van der Burgh AM, Tinnenbroek-Capel IE, Groenwold R, Kodde LP, Broggini GA, Gessler C, Schouten HJ.
PMID: 25964793
Front Plant Sci. 2015 Apr 27;6:286. doi: 10.3389/fpls.2015.00286. eCollection 2015.

Two methods were developed for the generation of cisgenic apples. Both have been successfully applied producing trees. The first method avoids the use of any foreign selectable marker genes; only the gene-of-interest is integrated between the T-DNA border sequences....

Cite
Krens FA, Schaart JG, van der Burgh AM, et al. Cisgenic apple trees; development, characterization, and performance. Front Plant Sci. 2015;6:286doi: 10.3389/fpls.2015.00286.
Krens, F. A., Schaart, J. G., van der Burgh, A. M., Tinnenbroek-Capel, I. E., Groenwold, R., Kodde, L. P., Broggini, G. A., Gessler, C., & Schouten, H. J. (2015). Cisgenic apple trees; development, characterization, and performance. Frontiers in plant science, 6286. https://doi.org/10.3389/fpls.2015.00286
Krens, Frans A, et al. "Cisgenic apple trees; development, characterization, and performance." Frontiers in plant science vol. 6 (2015): 286. doi: https://doi.org/10.3389/fpls.2015.00286
Krens FA, Schaart JG, van der Burgh AM, Tinnenbroek-Capel IE, Groenwold R, Kodde LP, Broggini GA, Gessler C, Schouten HJ. Cisgenic apple trees; development, characterization, and performance. Front Plant Sci. 2015 Apr 27;6:286. doi: 10.3389/fpls.2015.00286. eCollection 2015. PMID: 25964793; PMCID: PMC4410516.
Copy Download .nbib Format: NLM
Orientational ordering of passivating ligands on CdS nanorods in solution generates strong rod-rod interactions.

Nano letters

Widmer-Cooper A, Geissler P.
PMID: 24295449
Nano Lett. 2014 Jan 08;14(1):57-65. doi: 10.1021/nl403067p. Epub 2013 Dec 10.

We present the first nearly atomistic molecular dynamics study of nanorod-nanorod association in explicit solvent, showing that inter-rod forces can be dominated by microscopic factors absent in common continuum descriptions. Specifically, we find that alkane ligands on faceted CdS...

Cite
Widmer-Cooper A, Geissler P. Orientational ordering of passivating ligands on CdS nanorods in solution generates strong rod-rod interactions. Nano Lett. 2013;14(1):57-65doi: 10.1021/nl403067p.
Widmer-Cooper, A., & Geissler, P. (2014). Orientational ordering of passivating ligands on CdS nanorods in solution generates strong rod-rod interactions. Nano letters, 14(1), 57-65. https://doi.org/10.1021/nl403067p
Widmer-Cooper, Asaph, and Geissler, Phillip. "Orientational ordering of passivating ligands on CdS nanorods in solution generates strong rod-rod interactions." Nano letters vol. 14,1 (2014): 57-65. doi: https://doi.org/10.1021/nl403067p
Widmer-Cooper A, Geissler P. Orientational ordering of passivating ligands on CdS nanorods in solution generates strong rod-rod interactions. Nano Lett. 2014 Jan 08;14(1):57-65. doi: 10.1021/nl403067p. Epub 2013 Dec 10. PMID: 24295449.
Copy Download .nbib Format: NLM
Active pneumatic control of centrifugal microfluidic flows for lab-on-a-chip applications.

Lab on a chip

Clime L, Brassard D, Geissler M, Veres T.
PMID: 25860103
Lab Chip. 2015 Jun 07;15(11):2400-11. doi: 10.1039/c4lc01490a.

This paper reports a novel method of controlling liquid motion on a centrifugal microfluidic platform based on the integration of a regulated pressure pump and a programmable electromechanical valving system. We demonstrate accurate control over the displacement of liquids...

Cite
Clime L, Brassard D, Geissler M, et al. Active pneumatic control of centrifugal microfluidic flows for lab-on-a-chip applications. Lab Chip. 2015;15(11):2400-11doi: 10.1039/c4lc01490a.
Clime, L., Brassard, D., Geissler, M., & Veres, T. (2015). Active pneumatic control of centrifugal microfluidic flows for lab-on-a-chip applications. Lab on a chip, 15(11), 2400-11. https://doi.org/10.1039/c4lc01490a
Clime, Liviu, et al. "Active pneumatic control of centrifugal microfluidic flows for lab-on-a-chip applications." Lab on a chip vol. 15,11 (2015): 2400-11. doi: https://doi.org/10.1039/c4lc01490a
Clime L, Brassard D, Geissler M, Veres T. Active pneumatic control of centrifugal microfluidic flows for lab-on-a-chip applications. Lab Chip. 2015 Jun 07;15(11):2400-11. doi: 10.1039/c4lc01490a. PMID: 25860103.
Copy Download .nbib Format: NLM
Erratum: Moisture-responsive films of cellulose stearoyl esters showing reversible shape transitions.

Scientific reports

Zhang K, Geissler A, Standhardt M, Mehlhase S, Gallei M, Chen L, Thiele CM.
PMID: 26244852
Sci Rep. 2015 Aug 05;5:12390. doi: 10.1038/srep12390.

No abstract available.

Cite
Zhang K, Geissler A, Standhardt M, et al. Erratum: Moisture-responsive films of cellulose stearoyl esters showing reversible shape transitions. Sci Rep. 2015;5:12390doi: 10.1038/srep12390.
Zhang, K., Geissler, A., Standhardt, M., Mehlhase, S., Gallei, M., Chen, L., & Thiele, C. M. (2015). Erratum: Moisture-responsive films of cellulose stearoyl esters showing reversible shape transitions. Scientific reports, 512390. https://doi.org/10.1038/srep12390
Zhang, Kai, et al. "Erratum: Moisture-responsive films of cellulose stearoyl esters showing reversible shape transitions." Scientific reports vol. 5 (2015): 12390. doi: https://doi.org/10.1038/srep12390
Zhang K, Geissler A, Standhardt M, Mehlhase S, Gallei M, Chen L, Thiele CM. Erratum: Moisture-responsive films of cellulose stearoyl esters showing reversible shape transitions. Sci Rep. 2015 Aug 05;5:12390. doi: 10.1038/srep12390. PMID: 26244852; PMCID: PMC4525778.
Copy Download .nbib Format: NLM
Complete Genome Sequence of the Autographa californica Multiple Nucleopolyhedrovirus Strain E2.

Genome announcements

Maghodia AB, Jarvis DL, Geisler C.
PMID: 25502662
Genome Announc. 2014 Dec 11;2(6). doi: 10.1128/genomeA.01202-14.

Many vectors that are commonly used in the baculovirus/insect cell system (BICS) are derived from the Autographa californica multiple nucleopolyhedrovirus (AcMNPV) strain E2. To facilitate work with these vectors, we sequenced the E2 genome, compared it to that of...

Cite
Maghodia AB, Jarvis DL, Geisler C. Complete Genome Sequence of the Autographa californica Multiple Nucleopolyhedrovirus Strain E2. Genome Announc. 2014;2(6)doi: 10.1128/genomeA.01202-14.
Maghodia, A. B., Jarvis, D. L., & Geisler, C. (2014). Complete Genome Sequence of the Autographa californica Multiple Nucleopolyhedrovirus Strain E2. Genome announcements, 2(6), . https://doi.org/10.1128/genomeA.01202-14
Maghodia, Ajay B, et al. "Complete Genome Sequence of the Autographa californica Multiple Nucleopolyhedrovirus Strain E2." Genome announcements vol. 2,6 (2014). doi: https://doi.org/10.1128/genomeA.01202-14
Maghodia AB, Jarvis DL, Geisler C. Complete Genome Sequence of the Autographa californica Multiple Nucleopolyhedrovirus Strain E2. Genome Announc. 2014 Dec 11;2(6). doi: 10.1128/genomeA.01202-14. PMID: 25502662; PMCID: PMC4263824.
Copy Download .nbib Format: NLM
The benefits of skull stripping in the normalization of clinical fMRI data.

NeuroImage. Clinical

Fischmeister FP, Höllinger I, Klinger N, Geissler A, Wurnig MC, Matt E, Rath J, Robinson SD, Trattnig S, Beisteiner R.
PMID: 24273720
Neuroimage Clin. 2013 Sep 30;3:369-80. doi: 10.1016/j.nicl.2013.09.007. eCollection 2013.

Establishing a reliable correspondence between lesioned brains and a template is challenging using current normalization techniques. The optimum procedure has not been conclusively established, and a critical dichotomy is whether to use input data sets which contain skull signal,...

Cite
Fischmeister FP, Höllinger I, Klinger N, et al. The benefits of skull stripping in the normalization of clinical fMRI data. Neuroimage Clin. 2013;3:369-80doi: 10.1016/j.nicl.2013.09.007.
Fischmeister, F. P., Höllinger, I., Klinger, N., Geissler, A., Wurnig, M. C., Matt, E., Rath, J., Robinson, S. D., Trattnig, S., & Beisteiner, R. (2013). The benefits of skull stripping in the normalization of clinical fMRI data. NeuroImage. Clinical, 3369-80. https://doi.org/10.1016/j.nicl.2013.09.007
Fischmeister, F Ph S, et al. "The benefits of skull stripping in the normalization of clinical fMRI data." NeuroImage. Clinical vol. 3 (2013): 369-80. doi: https://doi.org/10.1016/j.nicl.2013.09.007
Fischmeister FP, Höllinger I, Klinger N, Geissler A, Wurnig MC, Matt E, Rath J, Robinson SD, Trattnig S, Beisteiner R. The benefits of skull stripping in the normalization of clinical fMRI data. Neuroimage Clin. 2013 Sep 30;3:369-80. doi: 10.1016/j.nicl.2013.09.007. eCollection 2013. PMID: 24273720; PMCID: PMC3814956.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 301 entries